Please assess the completion status of the following clinical trial:

Trial Title: Testosterone Replacement Therapy in Chronic Spinal Cord Injury

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2/PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Males 18-49 years of age~* Chronic spinal cord injury~* Normal prostate specific antigen levels and digital rectal exam~* No known cardiovascular disease~* Subjects with total testosterone \> 4 ng/ml~* Subjects with total testosterone \> 4 ng/ml~Exclusion Criteria:~* Females~* Known coronary heart and/or artery disease, diabetes mellitus~* Previous or current cancer~* Current or previous anabolic steroid use~* Acute inter-current illness~* Abnormal liver function test (\>1.5 times normal values) at baseline~* Prostate specific antigen above normal~* Abnormal digital rectal exam at baseline suggestive of malignancy~* Current alcohol or drug abuse~* Significant psychological disorders

- Gender: MALE
- Minimum Age: 18 Years
- Maximum Age: 49 Years
- Healthy Volunteers: f

Study Arms:
- Testosterone Replacement Therapy (Type: EXPERIMENTAL): Subjects with Low Testosterone (Hypogonadal) Receive Testosterone Transdermal System (Androderm 5 mg patch)
- No Intervention (Type: NO_INTERVENTION): Subjects with normal testosterone levels (eugonadal) participated in identical outcome measurements at parallel time points.

Based on this trial design, predict the completion outcome and termination type (if applicable).